| Thomas Michael Doers, MD | |
|
975 Port Washington Road, Suite 110, Grafton, WI 53024-9201 | |
| (262) 387-8300 | |
| Not Available |
| Full Name | Thomas Michael Doers |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 975 Port Washington Road, Grafton, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700868957 | NPI | - | NPPES |
| 32599800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 41253 (Wisconsin) | Primary |
| 207XS0117X | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine | 41253-020 (Wisconsin) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Michael Doers, MD 3003 W Good Hope Rd, Milwaukee, WI 53209-2042 Ph: (414) 352-3100 | Thomas Michael Doers, MD 975 Port Washington Road, Suite 110, Grafton, WI 53024-9201 Ph: (262) 387-8300 |
News Archive
The risk of catching some nasty germ in the Hudson River just started looking nastier. Disease-causing microbes have long been found swimming there, but now researchers have documented antibiotic-resistant strains in specific spots, from the Tappan Zee Bridge to lower Manhattan.
Today, the U.S. Food and Drug Administration approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns).
group of doctors has created a post-doctorate program to provide rural communities with a pipeline of providers, The Iowa Independent reports.
Organs-on-Chips technology has entered the mainstream and has reached 150 installations for use by researchers across many industries, including 10 of the top 25 biopharmaceutical companies, as well as leading international academic research centers and U.S. government laboratories, including the U.S. FDA through a collaborative agreement and the U.S. Army.
Array BioPharma today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the NEMO trial. The study met its primary endpoint of improving progression-free survival (PFS) compared with dacarbazine treatment.
› Verified 8 days ago
Eric J. Belin, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 | |
Omar J. Darr, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Road, Suite 110, Grafton, WI 53024 Phone: 262-387-8300 | |
Nathan J Kopydlowski, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 | |
Dr. Rafael Walker -santiago, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 | |
Michael J Anderson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Road, Suite 110, Grafton, WI 53024 Phone: 262-387-8300 | |
Matthew Paul Wichman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Suite 110, Grafton, WI 53024 Phone: 262-387-8300 |